Magna Gold Corp. Appoints Colin Sutherland as Director
TORONTO, Nov. 26, 2018 (GLOBE NEWSWIRE) — Magna Gold Corp. (TSXV: MGR.P) (the “Corporation”), is pleased to announce the appointment […]
Arbutus Appoints Dr. Frank Torti as Chairman of its Board of Directors
WARMINSTER, Pa., Nov. 26, 2018 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic […]
Japan Smaller Capitalization Fund, Inc. Announces Results of Annual Meeting of Shareholders
NEW YORK, Nov. 26, 2018 (GLOBE NEWSWIRE) — Japan Smaller Capitalization Fund, Inc. (NYSE: JOF) (the “Fund”) announced that the […]
Electronics For Imaging, Inc. Proposes Offering of $130 Million Convertible Senior Notes Due 2023
FREMONT, Calif., Nov. 26, 2018 (GLOBE NEWSWIRE) — Electronics For Imaging, Inc. (Nasdaq: EFII) (“EFI” or the “Company”) announced today […]
TSX News -
IMV Leadership to Present Respiratory Syncytial Virus (RSV) Research at RespiDART 2018
DARTMOUTH, Nova Scotia, Nov. 26, 2018 (GLOBE NEWSWIRE) — IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage immuno-oncology corporation, […]
Ferroglobe Reports Results for Third Quarter of 2018
Sales of $527 million; Net Loss of $3 million; Adjusted EBITDA of $45 million Q3 sales of $526.8 million, compared […]
Murphy USA Welcomes Hon. Jeanne L. Phillips to Board of Directors
EL DORADO, Ark., Nov. 26, 2018 (GLOBE NEWSWIRE) — Murphy USA Inc. (NYSE:MUSA) is pleased to announce that the Board […]
Abeona Therapeutics Announces CEO Transition
Dr. Carsten Thiel to Depart Company Immediately; Dr. João Siffert Appointed Interim CEO NEW YORK and CLEVELAND, Nov. 26, 2018 […]
Focus Financial Partners to Present at the Goldman Sachs U.S. Financial Services Conference 2018
NEW YORK, Nov. 26, 2018 (GLOBE NEWSWIRE) — Focus Financial Partners Inc. (Nasdaq: FOCS), a leading partnership of independent, fiduciary […]
Osiris Therapeutics, Inc. Appoints Samson Tom, PhD, MBA to Serve as President and Chief Executive Officer
COLUMBIA, Md., Nov. 26, 2018 (GLOBE NEWSWIRE) — Osiris Therapeutics, Inc. (NASDAQ: OSIR), a regenerative medicine company focused on developing […]
